PT-141 (Bremelanotide) 10mg
PT-141 / Bremelanotide (CX-007) | 10mg | Lyophilised Peptide
PT-141 (Bremelanotide) is a cyclic heptapeptide and melanocortin receptor agonist derived from Melanotan II. Unlike Melanotan II, PT-141 does not directly affect skin pigmentation, instead acting primarily on the CNS via MC3R and MC4R receptor activation. Research has focused on its role in arousal pathway modulation and libido-related neurological mechanisms in preclinical models.
Compound Information:
- Type: Melanocortin receptor agonist (MC3R/MC4R)
- Molecular Weight: 1,025.2 Da
- Purity: >99% (HPLC verified)
- Format: Lyophilised powder
- Storage: 2–8°C, protect from light
What's Included:
- 1 × PT-141 10mg vial
- Certificate of Analysis available on request
⚠ FOR RESEARCH USE ONLY. This product is intended solely for in vitro laboratory and scientific research purposes. Not for human or veterinary consumption. Not a medicine.
The Difference
Pharmaceutical Purity
GMP-certified synthesis to 99.9%+ purity. No fillers, no binders. Every batch independently verified before it leaves our facility.
HPLC Verified
Third-party laboratory analysis on every single batch. Certificate of Analysis included with every order. Available on request for any product.
Precision Formats
Lyophilised vials and pre-loaded pen formats. Exact milligram formulations. Clinical research accuracy in every format we offer.
Fast UK Delivery
UK orders dispatched within 48 hours of confirmation. International shipping available worldwide. Discreet outer packaging. Tracked from our facility to your door.
Researcher Reviews
"Reta Pen arrived quickly, cold-packed perfectly. CoA was included as promised. Quality is clearly pharmaceutical grade. Only supplier I'll use going forward."
"GHK-Cu 100mg — arrived well packaged, purity documentation perfect. Premium quality and fast delivery. The standard others should aspire to."
"Stacked BPC-157 and NAD+ — noticeably better than previous suppliers. Full documentation, fast dispatch, professional packaging throughout."